Stock MarketROI
Open
HSIC

HSIC

Healthcare · Medical Distribution

$81.54+0.55%
Mkt Cap: $9.29B

Performance

HSIC (HSIC) Stock Analysis 2026

Rule-based · Updated daily · Not financial advice

HSIC (HSIC) operates in the Medical Distribution space within the Healthcare sector. With a market cap of $9.3B, it qualifies as a small-cap company. Growth is moderate and the business remains profitable, offering a balanced risk/reward profile compared to high-multiple peers.

Bull Case2
  • Forward P/E (13.8×) is lower than trailing P/E (24.6×) — analysts expect earnings to improve
  • Revenue growth of 6% YoY shows solid business momentum
Bear Case3
  • Thin profit margin of 3.0% — little buffer against cost increases
  • High debt-to-equity of 77.75× increases financial risk, especially with elevated interest rates
  • No dividend history — total return depends entirely on price appreciation

Verdict

Caution

More risks than strengths. Consider waiting for fundamentals to improve before adding.

AI Insight

Powered by Claude

AI-generated analysis for informational purposes only. Not financial advice.

Related Articles

Revenue & Results

Dividends

This stock does not pay dividends.

If You Had Invested…

Hypothetical return based on historical prices

$

* Dividend reinvestment calculated at ex-date price. For informational purposes only.

Earnings

Next Earnings

Aug 4, 2026

49

days

EPS (TTM)

$3.31

P/E (TTM)

24.6

Fwd P/E

13.8

Earnings History

SEC EDGAR · official filings

SEC filings

SEC Filings

Official EDGAR documents

All filings

Key Statistics

Valuation

Market Cap$9.29B
P/E Ratio24.63
Forward P/E13.78
P/B Ratio
PEG Ratio1.79
EPS (TTM)$3.31

Trading

Open
Day High
Day Low
52W High$89.29
52W Low$61.95
Volume
Avg Volume (3M)1,385,311
Beta0.82

Dividends

Dividend Yield
Annual Rate
Ex-Div Date
Payout Ratio0.00%

Profitability

Profit Margin2.95%
Operating Margin5.85%
ROE8.76%
ROA4.35%
Revenue Growth6.30%
Earnings Growth4.50%

Balance Sheet

Total Revenue$13.38B
Total Debt$3.75B
Debt / Equity77.75
Current Ratio1.36
Free Cash Flow$290.12M

Fair Value Estimates

Current price: $81.54

Graham Number

√(22.5 × EPS × Book Value)

$46.11

-43.5% downside

Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.

Bazin Ceiling Price

Avg. Annual DPS (5Y) ÷ 6%

N/A

Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.

These are simplified estimates. Not financial advice.

Buy & Hold Checklist

Quality criteria for long-term holding

5/10

63% score

Pays dividends

No dividend history found

Dividend consistency (5Y+)

Uninterrupted dividend payments for at least 5 years

ROE above 10%

8.8%

Return on equity — measures how efficiently capital is used

Positive profit margin

3.0%

Net profit margin must be positive — company earns more than it spends

Revenue growth (annual)

+6.3%

Annual revenue must be growing compared to the prior year

Earnings growth (annual)

+4.5%

Annual earnings must be growing compared to the prior year

Debt/Equity below 2×

77.75×

Low financial leverage reduces risk of distress

Current ratio above 1

1.36×

Short-term assets must cover short-term liabilities

Daily liquidity above $5M

$113M/day

High trading volume ensures easy entry and exit

Dividend yield above 0%

Stock must distribute income to shareholders

Related Assets

Healthcare

About HSIC

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Sector

Healthcare

Industry

Medical Distribution

Location

Melville, United States

Employees

25,000